SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

AstraZeneca’s Enhertu approved in EU for 1L HER2-positive mBC

AstraZeneca PLC said Enhertu has been approved in the EU for 1L HER2-positive mBC.

AZN

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.